FFL
ADMA icon

Future Fund LLC’s ADMA Biologics ADMA Stock Holding History

Future Fund LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
184,016
+86,584
+89% +$1.37M 0.58% 78
2025
Q4 		$1.78M Buy
97,432
+33,312
+52% +$561K 0.56% 63
2025
Q3 		$940K Buy
64,120
+23,945
+60% +$410K 0.33% 126
2025
Q2 		$732K Buy
+40,175
New +$819K 0.33% 127

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Future Fund LLC's ADMA Position: Q1 2026 in Review

Future Fund LLC increased its ADMA Biologics (ADMA) stake by 89% in Q1 2026, buying an estimated $1.37M and bringing the position to 184,016 shares worth $1.66M. The position accounts for 0.58% of the portfolio, ranked #78.

Future Fund LLC first reported a position in ADMA in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.78M in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Future Fund LLC held 184,016 shares of ADMA Biologics worth $1.66M as of Q1 2026.
  • Future Fund LLC bought 86,584 ADMA Biologics shares in Q1 2026, an estimated $1.37M.
  • ADMA Biologics made up 0.58% of Future Fund LLC's portfolio in Q1 2026, its #78 holding.
  • Future Fund LLC first reported a position in ADMA Biologics in Q2 2025 and has held it in 4 quarters since.
  • Future Fund LLC's ADMA Biologics position peaked at $1.78M in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Future Fund LLC's 13F filing for Q1 2026, filed 6 May 2026.